| Zugriffsnummer | 44652 |
| Dokumenttyp | Zeitschriftenartikel |
| Peer Review | mit Peer Review |
| Sprache | Englisch |
| Titel | Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions |
| Autor(in); Institution |
Schuemann, Jan; Massachusetts General Hospital & Harvard Medical School, Department of Radiation Oncology, Boston, USA
Bagley, Alexander F.; The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA
Berbeco, Ross; Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Department of Radiation Oncology, Boston, USA
Bromma, Kyle; University of Victoria, Department of Physics and Astronomy, Victoria, CANADA
Butterworth, Karl T.; Queen’s University Belfast, Centre for Cancer Research and Cell Biology, Belfast, UK
Byrne, H.; The University of Sydney, Faculty of Science, Institute of Medical Physics, School of Physics, AUSTRALIA
Chithrani, Devika; University of Victoria, Department of Physics and Astronomy, Victoria, CANADA
Cho, Sang Hyun; The University of Texas, Department of Radiation Physics & Department of Imaging Physics, USA
Cook, Jason R.; NanoHybrids, Austin, USA
Favaudon, Vincent; University Paris Sud, Institut Curie, University Paris-Saclay, Orsay, FRANCE
Gholami, Y.; The University of Sydney, Faculty of Science, Institute of Medical Physics, School of Physics, AUSTRALIA
Gargioni, Elisabetta; University medical center Hamburg-Eppendorf, Department of Radiotherapy and Radiation Oncology, Hamburg, GERMANY
Hainfeld, James F.; Nanoporbes, Yaphank, USA
Hespeels, Felicien; University of Namur, NAmur Research Institute for LIfe Sciences (NARILIS), Laboratory of Analysis by Nuclear Reactions, Namur, BELGIUM
Heuskin, Anne-Catherine; University of Namur, NAmur Research Institute for LIfe Sciences (NARILIS), Laboratory of Analysis by Nuclear Reactions, Namur, BELGIUM
Ibeh, Udoka M.; Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Department of Radiation Oncology, Boston, USA
Kuncic, Z.; The University of Sydney, Faculty of Science, Institute of Medical Physics, School of Physics, AUSTRALIA; The University of Sydney Nano Institute, AUSTRALIA
Kunjachan, Sijumon; Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Department of Radiation Oncology, Boston, USA
Lacombe, Sandrine; University Paris-Saclay, University Paris Sud, Orsay, FRANCE
Lucas, Stephane; University of Namur, NAmur Research Institute for LIfe Sciences (NARILIS), Laboratory of Analysis by Nuclear Reactions, Namur, BELGIUM
Lux, Francois; NH TherAguix SAS, Villeurbanne, FRANCE; Universite Claude Bernard Lyon 1, Institut Lumiere Matiere, Lyon, FRANCE
McMahon, Stephen; Queen’s University Belfast, Centre for Cancer Research and Cell Biology, Belfast, UK
Nevozhay, Dmitry; The University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA; Far Eastern Federal University, School of Biomedicine, Vladivostok, RUSSIA
Ngwa, Wilfred; Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Department of Radiation Oncology, Boston, USA
Payne, J. Donald; Aurorad, Houston, USA
Penninckx, Sebastien; University of Namur, NAmur Research Institute for LIfe Sciences (NARILIS), Laboratory of Analysis by Nuclear Reactions, Namur, BELGIUM
Porcel, Erika; University Paris-Saclay, University Paris Sud, Orsay, FRANCE
Prise, Kevin M.; Queen’s University Belfast, Centre for Cancer Research and Cell Biology, Belfast, UK
Rabus, Hans; 6.5, Strahlenwirkung, PTB-Braunschweig
Rudek, Benedikt; Massachusetts General Hospital & Harvard Medical School, Department of Radiation Oncology, Boston, USA; 6.5, Strahlenwirkung, PTB-Braunschweig; Boston University, Boston, USA
Sanche, Leon; Université de Sherbrooke, Department of nuclear medicine and radiobiology, Sherbrooke, CANADA
Singh, Bijay; Northeastern University, Department of Physics, Boston, USA
Sokolov, Konstantin V.; The University of Texas MD Anderson Cancer Center, Department of Imaging Physics, Houston, USA; Rice University, Department of Bioengineering, Houston, USA; The University of Texas at Austin, Department of Biomedical Engineering, Austin, USA
Sridhar, Srinivas; Northeastern University, Department of Physics, Boston, USA
Sung, Wonmo; Massachusetts General Hospital & Harvard Medical School, Department of Radiation Oncology, Boston, USA
Tillement, Olivier; NH TherAguix SAS, Villeurbanne, FRANCE; Universite Claude Bernard Lyon 1, Institut Lumiere Matiere, Lyon, FRANCE
Virani, Needa; Brigham and Women’s Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Department of Radiation Oncology, Boston, USA
Yantasee, Wassana; Oregon Health & Science University, Department of Biomedical Engineering, Portland, USA
Krishnan, Sunil; Mayo Clinic Florida, Department of Radiation Oncology, Jacksonville, USA
|
| Quelle/Jahr | Physics in Medicine and Biology: 65 (2020), 21, 1 - 64 |
| Artikelnummer | 21RM02 |
| ISSN | 0031-9155 (PRINT) ; 1361-6560 (ONLINE) |
| DOI | |
| Verlag | Bristol: IOP Publishing |
| Freie Schlagworte | Metallic nanoparticles ; dose enhancement ; theranostic |
| Zusammenfassung | This roadmap outlines the potential roles of metallic nanoparticles (MNPs) in the field of radiation therapy. MNPs made up of a wide range of materials (from Titanium, Z=22, to Bismuth, Z=83) and a similarly wide spectrum of potential clinical applications, including diagnostic, therapeutic (radiation dose enhancers, hyperthermia inducers, drug delivery vehicles, vaccine adjuvants, photosensitizers, enhancers of immunotherapy, …) and theranostic (combining both diagnostic and therapeutic), are being fabricated and evaluated. This roadmap covers contributions from experts in these topics summarizing their view of the current status and challenges, as well as expected advancements in technology to address these challenges. |
| Themenbereich der Metrologie | Ionisierende Strahlung |
| Förderinformationen (1) |
Förderername: Deutsche Forschungsgemeinschaft (DFG)
Förderer ID: 0000 0001 2096 9829 Förderer ID Typ: ISNI Titel der Förderung: Elektronenemissionsspektren von Gold-Nanopartikeln zur Dosisberechnung in der Strahlentherapie Förderungsnummer: 386872118 URI der Förderung: https://gepris.dfg.de/gepris/projekt/386872118 |
Zitierung
Schuemann, J., Bagley, A. F., Berbeco, R., Bromma, K., Butterworth, K. T., Byrne, H., Chithrani, D., Cho, S. H., Cook, J. R., Favaudon, V., Gholami, Y., Gargioni, E., Hainfeld, J. F., Hespeels, F., Heuskin, A.-C., Ibeh, U. M., Kuncic, Z., Kunjachan, S., Lacombe, S., Lucas, S., Lux, F., McMahon, S., Nevozhay, D., Ngwa, W., Payne, J. D., Penninckx, S., Porcel, E., Prise, K. M., Rabus, H., Rudek, B., Sanche, L., Singh, B., Sokolov, K. V., Sridhar, S., Sung, W., Tillement, O., Virani, N., Yantasee, W., & Krishnan, S. (2020). Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Physics in Medicine and Biology, 65(21), 1–64. https://doi.org/10.1088/1361-6560/ab9159